Related references
Note: Only part of the references are listed.EGFR tyrosine kinase inhibitors in lung cancer: An evolving story
Lecia V. Sequist et al.
ANNUAL REVIEW OF MEDICINE (2008)
Will targeted therapy hold its promise? An evidence-based review
David Murdoch et al.
CURRENT OPINION IN ONCOLOGY (2008)
Targeting survivin in cancer therapy
Marzia Pennati et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
EGFR tyrosine kinase inhibitors for the treatment of NSCLC in East Asia: present and future
Chih-Hsin Yang
LUNG CANCER (2008)
Treatment of non-small cell lung cancer, stage IIIB - ACCP evidence-based clinical practice guidelines (2nd edition)
Janws R. Jett et al.
CHEST (2007)
The Survivin-mediated radioresistant phenotype of glioblastomas is regulated by RhoA and inhibited by the green tea polyphenol (-)-epigallocatechin-3-gallate
N McLaughlin et al.
BRAIN RESEARCH (2006)
Radiotherapy sensitization by tumor-specific TRAIL gene targeting improves survival of mice bearing human non-small cell lung cancer
XC Zhang et al.
CLINICAL CANCER RESEARCH (2005)
Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells
K Kami et al.
SURGERY (2005)
Radiation therapy potentiates effective oncolytic viral therapy in the treatment of lung cancer
PS Adusumilli et al.
ANNALS OF THORACIC SURGERY (2005)
Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer
F Rödel et al.
CANCER RESEARCH (2005)
Real-time quantification of microRNAs by stem-loop RT-PCR
CF Chen et al.
NUCLEIC ACIDS RESEARCH (2005)
Survivin as a therapeutic target for radiation sensitization in lung cancer
B Lu et al.
CANCER RESEARCH (2004)
The care of the lung cancer patient in the 21st century: A new age
W Smith et al.
SEMINARS IN ONCOLOGY (2004)
Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms
A Chakravarti et al.
ONCOGENE (2004)
Adenovirus-mediated transfer of siRNA against survivin induced apoptosis and attenuated tumor cell growth in vitro and in vivo
H Uchida et al.
MOLECULAR THERAPY (2004)
The rationale and potential of combining novel biologic therapies with radiotherapy: Focus on non-small cell lung cancer
RS Herbst et al.
SEMINARS IN ONCOLOGY (2003)
Survivin as a radioresistance factor in pancreatic cancer
K Asanuma et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2000)
Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16INK4a and Cdk2/Cyclin E complex activation
A Suzuki et al.
ONCOGENE (2000)
Adenovirus-mediated p14ARF gene transfer in human mesothelioma cells
CT Yang et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
